Artwork

Kandungan disediakan oleh Marcus Whitney. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Marcus Whitney atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Player FM - Aplikasi Podcast
Pergi ke luar talian dengan aplikasi Player FM !

78 - Market Meltdown | What You Need to Know About the Latest Volatility

40:16
 
Kongsi
 

Manage episode 433423959 series 2553216
Kandungan disediakan oleh Marcus Whitney. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Marcus Whitney atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.

In this episode, Marcus covers a range of crucial topics, starting with the recent global stock market slide and its impact on the Dow, S&P 500, and Nasdaq, followed by a discussion on whether the Fed can still achieve a soft landing as rate cuts approach. He also highlights the market's rebound driven by jobless claims and discusses significant life sciences investments by venBio and TPG. Marcus then turns to healthcare policy, exploring Medicare's new coverage of cutting-edge medical devices, Centene's exit from six Medicare Advantage markets, and CVS's decision to slash profit guidance amid rising insurance costs. Additionally, he examines Walgreens' potential sale of its VillageMD stake and the stark outlook for Charles River Labs. The episode also touches on the ongoing layoffs in biotech, Hims & Hers' compounding pharmacy acquisition, Annalise.ai's Medicare NTAP approval, and the departure of an OpenAI co-founder to rival Anthropic.

------🔎RESOURCES🔎

Links:

00:00 - Intro

1:30 - Stock Market News, Aug. 5, 2024: Dow, S&P 500, Nasdaq Slide Amid Global Selloff - WSJ

4:45 - Can Fed Officials Still Nail the Landing? As Rate Cuts Near, It's a Moment of Truth - NYT

6:14 - Stock Market News, Aug. 8, 2024: S&P 500, Nasdaq, Bond Yields Jump After Jobless - WSJ

8:28 - ClaimsVenture capital veteran venBio raises $528M for life sciences investment - Fierce

8:35 - TPG tops up funds to $580M for investments across the life sciences spectrum - Fierce

11:01 - Cutting-edge medical devices will soon be covered by Medicare - Axios

13:17 - Centene to exit 6 Medicare Advantage markets: Stephens bank - Modern Healthcare

15:05 - CVS slashes profit guidance, will cut $2 billion in expenses as insurance costs climb - CNBC

18:08 - Walgreens may sell entire VillageMD stake - Modern Healthcare

22:09 - Charles River Labs Plummets 14% On 'Bleaker' Expectations For 2024 - IBD

25:53 - Fierce Biotech Layoff Tracker 2024 - Fierce

28:09 - Hims & Hers CEO defends compounding pharmacy acquisition - AXIOS

32:51 -

HF Site
YOUTUBE
INSTAGRAM
TWITTER
FACEBOOK
LINKEDIN
TIKTOK

  continue reading

93 episod

Artwork
iconKongsi
 
Manage episode 433423959 series 2553216
Kandungan disediakan oleh Marcus Whitney. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Marcus Whitney atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.

In this episode, Marcus covers a range of crucial topics, starting with the recent global stock market slide and its impact on the Dow, S&P 500, and Nasdaq, followed by a discussion on whether the Fed can still achieve a soft landing as rate cuts approach. He also highlights the market's rebound driven by jobless claims and discusses significant life sciences investments by venBio and TPG. Marcus then turns to healthcare policy, exploring Medicare's new coverage of cutting-edge medical devices, Centene's exit from six Medicare Advantage markets, and CVS's decision to slash profit guidance amid rising insurance costs. Additionally, he examines Walgreens' potential sale of its VillageMD stake and the stark outlook for Charles River Labs. The episode also touches on the ongoing layoffs in biotech, Hims & Hers' compounding pharmacy acquisition, Annalise.ai's Medicare NTAP approval, and the departure of an OpenAI co-founder to rival Anthropic.

------🔎RESOURCES🔎

Links:

00:00 - Intro

1:30 - Stock Market News, Aug. 5, 2024: Dow, S&P 500, Nasdaq Slide Amid Global Selloff - WSJ

4:45 - Can Fed Officials Still Nail the Landing? As Rate Cuts Near, It's a Moment of Truth - NYT

6:14 - Stock Market News, Aug. 8, 2024: S&P 500, Nasdaq, Bond Yields Jump After Jobless - WSJ

8:28 - ClaimsVenture capital veteran venBio raises $528M for life sciences investment - Fierce

8:35 - TPG tops up funds to $580M for investments across the life sciences spectrum - Fierce

11:01 - Cutting-edge medical devices will soon be covered by Medicare - Axios

13:17 - Centene to exit 6 Medicare Advantage markets: Stephens bank - Modern Healthcare

15:05 - CVS slashes profit guidance, will cut $2 billion in expenses as insurance costs climb - CNBC

18:08 - Walgreens may sell entire VillageMD stake - Modern Healthcare

22:09 - Charles River Labs Plummets 14% On 'Bleaker' Expectations For 2024 - IBD

25:53 - Fierce Biotech Layoff Tracker 2024 - Fierce

28:09 - Hims & Hers CEO defends compounding pharmacy acquisition - AXIOS

32:51 -

HF Site
YOUTUBE
INSTAGRAM
TWITTER
FACEBOOK
LINKEDIN
TIKTOK

  continue reading

93 episod

Tutti gli episodi

×
 
Loading …

Selamat datang ke Player FM

Player FM mengimbas laman-laman web bagi podcast berkualiti tinggi untuk anda nikmati sekarang. Ia merupakan aplikasi podcast terbaik dan berfungsi untuk Android, iPhone, dan web. Daftar untuk melaraskan langganan merentasi peranti.

 

Panduan Rujukan Pantas

Podcast Teratas